RHOV and adrenal cortex carcinoma: Furthermore, high expression levels of RHOV correlated with worse disease‐specific survival in patients with ACC, LUAD, PAAD, SKCM, and UVM, and were associated with a shorter progression‐free interval in patients with ACC and LUAD (Figs 6 and 7).